State Street Corp Day One Biopharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.59 Trillion
  • Q2 2025

A detailed history of State Street Corp transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,689,686 shares of DAWN stock, worth $16.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,689,686
Previous 2,706,699 0.63%
Holding current value
$16.5 Million
Previous $21.5 Million 18.55%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$6.16 - $7.97 $104,800 - $135,593
-17,013 Reduced 0.63%
2,689,686 $17.5 Million
Q1 2025

May 15, 2025
SELL
$7.93 - $13.21 $3.13 Million - $5.22 Million
-394,978 Reduced 12.73%
2,706,699 $21.5 Million
Q4 2024

Feb 14, 2025
BUY
$12.46 - $16.39 $3.46 Million - $4.55 Million
277,860 Added 9.84%
3,101,677 $39.3 Million
Q3 2024

Nov 14, 2024
SELL
$12.72 - $16.03 $38,198 - $48,138
-3,003 Reduced 0.11%
2,823,817 $39.3 Million
Q2 2024

Aug 14, 2024
SELL
$12.03 - $17.69 $818,797 - $1.2 Million
-68,063 Reduced 2.35%
2,826,820 $39 Million
Q1 2024

May 15, 2024
SELL
$13.56 - $17.46 $6.58 Million - $8.47 Million
-485,215 Reduced 14.36%
2,894,883 $47.8 Million
Q4 2023

Feb 14, 2024
BUY
$9.68 - $15.37 $4.3 Million - $6.83 Million
444,179 Added 15.13%
3,380,098 $49.3 Million
Q3 2023

Nov 14, 2023
SELL
$11.22 - $14.86 $4.69 Million - $6.22 Million
-418,407 Reduced 12.47%
2,935,919 $36 Million
Q2 2023

Aug 14, 2023
BUY
$11.74 - $14.47 $12.9 Million - $15.9 Million
1,097,535 Added 48.63%
3,354,326 $40.1 Million
Q1 2023

May 15, 2023
SELL
$12.75 - $23.41 $2.55 Million - $4.68 Million
-199,744 Reduced 8.13%
2,256,791 $30.2 Million
Q4 2022

Feb 14, 2023
BUY
$18.77 - $22.0 $7.79 Million - $9.13 Million
414,797 Added 20.32%
2,456,535 $52.9 Million
Q3 2022

Nov 15, 2022
BUY
$16.44 - $26.57 $27.7 Million - $44.7 Million
1,682,955 Added 469.07%
2,041,738 $40.9 Million
Q2 2022

Aug 15, 2022
BUY
$5.72 - $17.9 $815,483 - $2.55 Million
142,567 Added 65.94%
358,783 $6.42 Million
Q1 2022

May 16, 2022
BUY
$9.12 - $17.47 $243,731 - $466,885
26,725 Added 14.1%
216,216 $2.15 Million
Q4 2021

Feb 14, 2022
BUY
$15.65 - $26.33 $1.02 Million - $1.72 Million
65,459 Added 52.78%
189,491 $3.19 Million
Q3 2021

Nov 15, 2021
BUY
$20.0 - $27.92 $2.48 Million - $3.46 Million
124,032 New
124,032 $2.94 Million

Others Institutions Holding DAWN

# of Institutions
188
Shares Held
69.3M
Call Options Held
127K
Put Options Held
85.5K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $451M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email